Diseases of Aortic Valve

Cardiovascular
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Genesis Therapeutics
Genesis TherapeuticsCA - Burlingame
2 programs
Transcatheter aortic valve replacementN/A1 trial
Transcatheter aortic valve replacementN/A1 trial
Active Trials
NCT05580952UnknownEst. May 2024
NCT05607667CompletedEst. Jul 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Genesis TherapeuticsTranscatheter aortic valve replacement
Genesis TherapeuticsTranscatheter aortic valve replacement

Clinical Trials (2)

NCT05580952Genesis TherapeuticsTranscatheter aortic valve replacement

Clinical Trial in China

Start: Oct 2022Est. completion: May 2024
N/AUnknown
NCT05607667Genesis TherapeuticsTranscatheter aortic valve replacement

Clinical Trial in China for Aortic Valve Stenosis

Start: Oct 2022Est. completion: Jul 2024
N/ACompleted

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space